Armstrong-Indiana-Clarion Drug And Alcohol Commission, Inc.

Armstrong-Indiana-Clarion Drug And Alcohol Commission, Inc., a Pennsylvania-based nonprofit tax-exempt entity, operates as a federal grant recipient delivering substance abuse prevention and addiction services to northwestern Pennsylvania counties as both a prime grant recipient and sub-recipient under federal agency pass-through arrangements. The organization functions as the single county authority (SCA) for Armstrong, Indiana, and Clarion counties, with headquarters in Shelocta, Pennsylvania.

Armstrong-Indiana-Clarion's federal footprint centers on grant work rather than federal contracts. As a prime recipient, it holds a $125,000 Drug-Free Communities Support Program grant (CFDA 93.276) awarded by the Centers for Disease Control and Prevention on July 1, 2026, running through June 30, 2031, supporting youth substance use prevention through the Clarion Drug Free Coalition. That coalition, established in 2010 in response to the opioid crisis, targets prevention of alcohol, tobacco, nicotine, marijuana, and prescription medication misuse among youth and young adults in Clarion County, a rural county of 36,970 residents in northwestern Pennsylvania positioned between Erie and Pittsburgh. The grant funds years 6–10 of the award cycle, building on evidence-based prevention programs and sustainability strategies.

Sub-recipient work dominates the portfolio. The organization receives pass-through funding from the Pennsylvania Department of Drug and Alcohol Programs (multiple awards beginning in 2022 for comprehensive addiction services planning and implementation) and from the Pennsylvania Commission on Crime and Delinquency (federal RSAT funds, awarded beginning in December 2023, to expand medication-assisted treatment in the Armstrong County Jail-Based MAT Program, with individual sub-awards carrying up to $200,000). Additional sub-recipient work includes naloxone distribution and fentanyl and xylazine test strip provision funded through state pass-through mechanisms.

The top five funding sources account for 88% of recent awards, heavily concentrated within the Department of Health and Human Services. SAMHSA leads with 18 awards combined, followed by the Bureau of Justice Assistance (4 awards), HRSA (4 awards), and CDC (2 awards). Sub-awards significantly outnumber prime grants — 21 of 32 total awards (66%) are sub-recipient awards — positioning Armstrong-Indiana-Clarion as a grassroots implementation partner rather than a direct federal prime. Activity shows modest recent acceleration (4 awards in 2024, 4 awards in 2026 year-to-date), with cumulative dollars obligated across all federal sources at $21.4 million since 2008. The organization does not hold federal contracts or government-wide acquisition vehicles.